Danish biotech firm Symphogen enters multi-million dollar American partnership deal

The Danes will receive upfront payment and potential royalties for R&D efforts

The Danish biotech company Symphogen has entered into a strategic collaboration agreement with the US firm Baxalta that will see the Danes receive 175 million dollars (1.2 billion kroner) upfront, with the potential for future payments and royalties.

Symphogen specialises in antibody therapeutics for the treatment of cancer while Baxalta works with therapies for orphan diseases and underserved conditions in hematology, oncology and immunology.

Different strengths
According to the terms of the partnership, Symphogen will work on the development of six so-called novel immune checkpoint therapies in the treatment of rare diseases, whereafter Baxalta will have the exclusive option rights to commercialise the products worldwide.

Kirsten Drejer, the CEO of Symphogen, said the two parties brought different strengths to the table.

“Baxalta’s dedication to delivering transformative therapies and its global commercial presence make it an ideal strategic partner for Symphogen, as we complement Baxalta with R&D competencies within the immuno-oncology area,” she said.

“We look forward to providing Baxalta with innovative immuno-oncology product candidates under this broad collaboration.”

TOP STORIES

  • Diplomatic tensions between US and Denmark after spying rumors

    Diplomatic tensions between US and Denmark after spying rumors

    A Wall Street Journal article describes that the US will now begin spying in Greenland. This worries the Danish foreign minister, who wants an explanation from the US’s leading diplomat. Greenlandic politicians think that Trump’s actions increase the sense of insecurity

  • Diplomacy meets Westeros: a dinner with the King, Queen – and Jaime Lannister

    Diplomacy meets Westeros: a dinner with the King, Queen – and Jaime Lannister

    What do King Frederik X, Queen Mary, UN Secretary-General António Guterres, and Jaime Lannister have in common? No, this isn’t the start of a very specific Shakespeare-meets-HBO fanfiction — it was just Wednesday night in Denmark

  • Huge boost to halt dropouts from vocational education

    Huge boost to halt dropouts from vocational education

    For many years, most young people in Denmark have preferred upper secondary school (Gymnasium). Approximately 20 percent of a year group chooses a vocational education. Four out of 10 young people drop out of a vocational education. A bunch of millions aims to change that

  • Beloved culture house saved from closure

    Beloved culture house saved from closure

    At the beginning of April, it was reported that Kapelvej 44, a popular community house situated in Nørrebro, was at risk of closing due to a loss of municipality funding

  • Mette Frederiksen: “If you harm the country that is hosting you, you shouldn’t be here at all”

    Mette Frederiksen: “If you harm the country that is hosting you, you shouldn’t be here at all”

    With reforms to tighten the rules for foreigners in Denmark without legal residency, and the approval of a reception package for internationals working in the care sector, internationals have been under the spotlight this week. Mette Frederiksen spoke about both reforms yesterday.

  • Tolerated, but barely: inside Denmark’s departure centers

    Tolerated, but barely: inside Denmark’s departure centers

    Currently, around 170 people live on “tolerated stay” in Denmark, a status for people who cannot be deported but are denied residency and basic rights. As SOS Racisme draws a concerning picture of their living conditions in departure centers, such as Kærshovedgård, they also suggest it might be time for Denmark to reinvent its policies on deportation

Connect club

Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.

Sign up here

Career

Want to advertise your job with CPH Post?

Contact us

Jobs